What is USIOL?
Established in 1985, USIOL operates as a specialized manufacturer of high-quality intraocular lenses and associated surgical consumables. The company maintains a robust portfolio that includes injectors, viscoelastic gels, and sutures, all designed to meet the rigorous demands of modern ophthalmic surgery. By adhering to strict ISO 13485 certification standards and maintaining comprehensive FDA registration, USIOL has cultivated a reputation for reliability and regulatory excellence. Their market position is defined by a commitment to supporting ophthalmologists through superior product quality and responsive service, ensuring that their surgical tools remain a staple in clinical environments worldwide.
How much funding has USIOL raised?
USIOL has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in USIOL
PPP
Public-Private Partnership
What's next for USIOL?
The infusion of capital from this late-stage investment provides USIOL with the necessary liquidity to optimize its manufacturing infrastructure and potentially explore new product development avenues. As the company navigates the complexities of the global medical device landscape, this strategic backing will likely be directed toward enhancing supply chain efficiency and deepening market penetration. By leveraging its decades of industry experience, USIOL is well-positioned to capitalize on the growing demand for high-precision surgical equipment, ensuring long-term sustainability and continued innovation in the field of ophthalmology.
See full USIOL company page
